Preoperative Evaluation of Sellar and Parasellar Macrolesions by [18F]Fluorodeoxyglucose Positron Emission Tomography
- PMID: 28427982
- DOI: 10.1016/j.wneu.2017.04.032
Preoperative Evaluation of Sellar and Parasellar Macrolesions by [18F]Fluorodeoxyglucose Positron Emission Tomography
Abstract
Objective: Various diseases can occur in the sellar and suprasellar regions. The potential of [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) for the preoperative evaluation of sellar and parasellar lesions was investigated.
Methods: A total of 49 patients aged 8-82 years with sellar and parasellar macroscopic lesions (≥10 mm) underwent FDG PET. Twenty-two patients had pituitary adenomas, including 14 nonfunctioning and 8 growth hormone-secreting adenomas. Eleven patients had craniopharyngiomas, including 5 adamantinomatous and 6 squamous-papillary types. Eight patients had chordoma, 4 had meningioma, and 4 had a Rathke cleft cyst. The maximum standardized uptake value (SUVmax), and the ratio of the SUVmax in the tumor to the mean standardized uptake value in the normal cortex (T/N ratio) or in the normal white matter (T/W ratio) were calculated. The relationships between SUVmax, T/N ratio, and T/W ratio, and lesion disease were evaluated.
Results: Uptakes of FDG, including SUVmax, T/N ratio, and T/W ratio, were lower in chordoma and Rathke cleft cyst compared with pituitary adenoma. SUVmax, T/N ratio, and T/W ratio of nonfunctioning adenoma were significantly higher than those of growth hormone-secreting adenoma. SUVmax, T/N ratio, and T/W ratio of squamous-papillary type were significantly higher than those of the adamantinomatous type of craniopharyngioma.
Conclusions: FDG PET is useful for the preoperative diagnosis of sellar and parasellar macrolesions. High uptake in nonfunctioning pituitary adenoma, and low uptake in chordoma are significant. The difference in FDG uptake dependent on the histologic subtype may be related to the specific genetics of the craniopharyngioma subtype.
Keywords: Chordoma; Craniopharyngioma; FDG PET; Pituitary adenoma.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Diagnostic considerations of tumors of the sellar region according to their geometry and vector growth.Neurocirugia (Engl Ed). 2025 May-Jun;36(3):179-184. doi: 10.1016/j.neucie.2024.12.003. Epub 2024 Dec 12. Neurocirugia (Engl Ed). 2025. PMID: 39672469
-
[X-ray computed tomography of the sellar region].Pol Przegl Radiol Med Nukl. 1982 Jan-Jun;46(1-3):7-13. Pol Przegl Radiol Med Nukl. 1982. PMID: 7145742 Polish. No abstract available.
-
Endoscopic Endonasal Surgery for Tumors of the Cavernous Sinus: A Series of 234 Patients.World Neurosurg. 2017 Jul;103:713-732. doi: 10.1016/j.wneu.2017.04.096. Epub 2017 Apr 24. World Neurosurg. 2017. PMID: 28450229
-
Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke's cleft cyst with corticotroph adenoma.Pituitary. 2008;11(3):317-23. doi: 10.1007/s11102-007-0070-6. Pituitary. 2008. PMID: 17917812 Review.
-
Collision tumors composed of meningioma and growth hormone-secreting pituitary adenoma in the sellar region: Case reports and a literature review.Medicine (Baltimore). 2017 Dec;96(50):e9139. doi: 10.1097/MD.0000000000009139. Medicine (Baltimore). 2017. PMID: 29390316 Free PMC article. Review.
Cited by
-
Pituitary metastasis from renal cell carcinoma presenting with significant hyperprolactinemia, case report.Clin Case Rep. 2023 Aug 25;11(9):e7808. doi: 10.1002/ccr3.7808. eCollection 2023 Sep. Clin Case Rep. 2023. PMID: 37636878 Free PMC article.
-
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors.Front Endocrinol (Lausanne). 2023 May 3;14:1123267. doi: 10.3389/fendo.2023.1123267. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37206441 Free PMC article. Review.
-
Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study.Sci Rep. 2021 Jan 8;11(1):126. doi: 10.1038/s41598-020-80259-4. Sci Rep. 2021. PMID: 33420213 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical